Zobrazeno 1 - 10
of 1 741
pro vyhledávání: '"W, Scheithauer"'
Autor:
Arie Perry, Mark A. Watson, Rakesh Nagarajan, David H. Gutmann, Lorena Salavaggione, Ryan J. Emnett, Rebecca J. Gutmann, Guy M. Lindberg, Rosalie E. Ferner, Julia A. Bridge, Abhijit Guha, Richard A. Prayson, Tarik Tihan, Bernd W. Scheithauer, Christopher Dunham, Jacqueline E. Payton, Hrishikesh Deshmukh, Jinsheng Yu
Supplementary Materials and Methods; Supplementary Tables S1-S5.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f4d6726bf4f218641c59c7af28a29a3
https://doi.org/10.1158/1078-0432.22442091
https://doi.org/10.1158/1078-0432.22442091
Autor:
Arie Perry, Mark A. Watson, Rakesh Nagarajan, David H. Gutmann, Lorena Salavaggione, Ryan J. Emnett, Rebecca J. Gutmann, Guy M. Lindberg, Rosalie E. Ferner, Julia A. Bridge, Abhijit Guha, Richard A. Prayson, Tarik Tihan, Bernd W. Scheithauer, Christopher Dunham, Jacqueline E. Payton, Hrishikesh Deshmukh, Jinsheng Yu
Purpose: Malignant peripheral nerve sheath tumors (MPNST) are highly aggressive sarcomas with variable patient survival and few known prognostically relevant genomic biomarkers. To identify survival-associated genomic biomarkers, we performed high-re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef933e4c773d5d1ce13671527892ae29
https://doi.org/10.1158/1078-0432.c.6518913
https://doi.org/10.1158/1078-0432.c.6518913
Autor:
Roberto Buzzoni, W.P. Yong, S. Reingold, Joseph McKendrick, G.J.M. Creemers, Fernando Rivera, Dewi Vernerey, David Cunningham, G. Ravit, E. Van Cutsem, Jin-Tung Liang, A. de Gramont, Pia Österlund, G. Bodoky, Thierry André, J. Tabernero, W. Scheithauer, Randi Isaacs, Manel Rakez, S-A. Im, G. Fountzilas
Publikováno v:
Annals of Oncology
Annals of Oncology, Elsevier, 2020, 31, pp.246-256. ⟨10.1016/j.annonc.2019.12.006⟩
Annals of Oncology, Elsevier, 2020, 31, pp.246-256. ⟨10.1016/j.annonc.2019.12.006⟩
Background The bevacizumab-Avastin® adjuVANT (AVANT) study did not meet its primary end point of improving disease-free survival (DFS) with the addition of bevacizumab to oxaliplatin-based chemotherapy in stage III colon cancer (CC). We report here
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cfd78f076d1d408cc0e7322b124c0ad
https://doi.org/10.1016/j.annonc.2019.12.006
https://doi.org/10.1016/j.annonc.2019.12.006
Autor:
Luis V. Syro, Bernd W. Scheithauer, Kalman Kovacs, Rodrigo A. Toledo, Francisco J. Londoño, Leon D. Ortiz, Fabio Rotondo, Eva Horvath, Humberto Uribe
Publikováno v:
Clinics, Vol 67, Pp 43-48 (2012)
We briefly review the characteristics of pituitary tumors associated with multiple endocrine neoplasia type 1. Multiple endocrine neoplasia type 1 is an autosomal-dominant disorder most commonly characterized by tumors of the pituitary, parathyroid,
Externí odkaz:
https://doaj.org/article/2d1a9c2642fb4dfa85fbb8c93a5f665c
Autor:
Leon D. Ortiz, Luis V. Syro, Bernd W. Scheithauer, Fabio Rotondo, Humberto Uribe, Camilo E. Fadul, Eva Horvath, Kalman Kovacs
Publikováno v:
Clinics, Vol 67, Pp 119-123 (2012)
Temozolomide is an alkylating agent used in the treatment of gliomas and, more recently, aggressive pituitary adenomas and carcinomas. Temozolomide methylates DNA and, thereby, has antitumor effects. O6-methylguanine-DNA methyltransferase, a DNA repa
Externí odkaz:
https://doaj.org/article/59aea8a3095d41f9bc71f63cd9fe6da3
Publikováno v:
Endocrine pathology. 4(1)
The immunocytochemical profile of 300 clinically nonsecreting pituitary adenomas was investigated. All tumors were diagnosed, classified, and separated into null cell adenomas, oncocytomas, and gonadotroph adenomas according to their ultrastructural
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a71f6c07d9e4967b30c649d958616d44
https://pubmed.ncbi.nlm.nih.gov/32370437
https://pubmed.ncbi.nlm.nih.gov/32370437
Autor:
Ninette Amariglio, Abraham Hirshberg, Bernd W Scheithauer, Yoram Cohen, Ron Loewenthal, Luba Trakhtenbrot, Nurit Paz, Maya Koren-Michowitz, Dalia Waldman, Leonor Leider-Trejo, Amos Toren, Shlomi Constantini, Gideon Rechavi
Publikováno v:
PLoS Medicine, Vol 6, Iss 2, p e1000029 (2009)
BackgroundNeural stem cells are currently being investigated as potential therapies for neurodegenerative diseases, stroke, and trauma. However, concerns have been raised over the safety of this experimental therapeutic approach, including, for examp
Externí odkaz:
https://doaj.org/article/4e478578374944a7a1165c1f52756dbd
Autor:
S-E. Al-Batran, G. Seipelt, Sebastian Stintzing, Dominik Paul Modest, L. Fischer von Weikersthal, Alexander Kiani, Christoph Kahl, Arndt Stahler, J. C. von Einem, Thomas Decker, W. Scheithauer, Volker Heinemann, T. Kirchner, Lisa Miller-Phillips, Andreas Jung, Frank Kullmann, Ursula Vehling-Kaiser
Publikováno v:
Annals of Oncology. 31:S429
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f80b5d94a65a79449458e56f4076d6b8
https://doi.org/10.1016/j.annonc.2020.08.552
https://doi.org/10.1016/j.annonc.2020.08.552
Autor:
R. Salazar, A. Sobrero, Dirk Arnold, Michel Ducreux, Christophe Tournigand, V. Molnar, Martina Schmidt, M. Starke, David Cunningham, E. Wiegert, W. Scheithauer, M. Baumann, E. Van Cutsem
Publikováno v:
Annals of Oncology. 30:v868-v869
Background The TLR9 agonist lefitolimod broadly activates the innate and adaptive immune system. Based on encouraging data from the randomized phase II IMPACT trial, lefitolimod was evaluated in this phase III trial as switch maintenance treatment in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81786b30cc2c044c4cdd85cdd34323a4
https://doi.org/10.1093/annonc/mdz394.022
https://doi.org/10.1093/annonc/mdz394.022
Autor:
T. André, D. Vernerey, S.-A. Im, G.M. Bodoky, R. Buzzoni, S. Reingold, F. Rivera, J. McKendrick, W. Scheithauer, R. Geva, G. Fountzilas, W.P. Yong, R. Isaacs, P. Österlund, J.-T. Liang, G.-J. Creemers, E. Van Cutsem, D. Cunningham, J. Tabernero, A. De Gramont
Publikováno v:
Annals of Oncology. 30:v211
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b113705ec81ef3031b9c1af2729edf45
https://doi.org/10.1093/annonc/mdz246.036
https://doi.org/10.1093/annonc/mdz246.036